Lineage, Inc. (LINE) is the world's largest global temperature-controlled warehouse REIT (real estate investment trust). Published analyst targets on the stock span a wide range, from roughly $35 to $55. The overall average of those targets is approximately $43, which implies only a single-digit premium to the latest price and therefore falls short of a meaningful 10% threshold. Accordingly, the $46 figure used here is the average of the verified targets that sit above the current price, not a published consensus.
Views differ sharply. Morgan Stanley upgraded the shares to Overweight with a $47 target, citing a "compelling" risk/reward after the July 2026 lock-up expiration and a Tyson Foods revenue-cut overhang, pointing to stable demand, moderating supply, and cost initiatives. RBC Capital and Compass Point hold constructive views near $44 to $47. In contrast, J.P. Morgan carries a Sell rating near $37, and UBS lowered its target to $36 from $45, while Barclays downgraded to Equal-Weight with a $38 target. The dispersion reflects genuine disagreement over how quickly occupancy and margins can recover.
Lineage recently traded near $39.66, within a 52-week range of roughly $31.33 to $45.75. Reaching $46 would require about 16% appreciation, a substantial move that would also push the stock modestly above its prior high. The company's third-quarter 2026 revenue of $1.361 billion fell 1.2% year over year, and it reported a GAAP net loss of $173 million, or a $0.68 diluted loss per share. Same-warehouse economic occupancy rose 30 basis points to 82.5%. Full-year guidance calls for adjusted EBITDA (earnings before interest, taxes, depreciation, and amortization) of $1.25 billion to $1.27 billion and adjusted FFO per share of $2.86 to $2.98.
Lineage's scale, with roughly 498 facilities and about 3.1 billion cubic feet of capacity, gives it a leading position in the fragmented cold-storage market. Stabilizing food-supply-chain demand, slowing new capacity additions, and management's cost programs could support margin and occupancy improvement. The stock's dividend yield of roughly 5.4% and index inclusion may attract income-focused and passive capital. Morgan Stanley's upgrade and any subsequent positive earnings revisions would reinforce the case for a higher stock price target.
The clearest obstacle is profitability: the company remains net-loss making, with negative GAAP earnings and a payout that exceeds earnings. A 1.2% revenue decline and a 7% drop in adjusted EBITDA in the latest quarter signal soft demand. Leverage is elevated, with total debt near $8.4 billion and a debt-to-equity ratio around 0.95. Occupancy near 82.5% leaves room for improvement but also underscores slack. Downgrades from Barclays and UBS, plus sell-side targets near $35 to $38, reflect caution that the recovery may be slower than bulls expect.
The $46 target sits almost exactly at the 52-week high of $45.75, making that zone a clear resistance level that buyers would need to clear decisively. Support appears near the 200-day moving average around $38.74 and the 50-day average near $36.28, with the $31.33 cycle low below. A sustained move above $46 would require the stock to break out of the upper boundary of its long-term range, a technically meaningful event rather than a routine advance.
Analyst targets typically reflect a roughly 12-month horizon, though individual assumptions vary. Investors should watch occupancy and same-warehouse trends, adjusted FFO growth, and any updates to full-year guidance. Further analyst target revisions, interest-rate expectations that affect REIT valuations, debt refinancing progress, and the outcome of litigation related to a fire incident are also relevant. Quarterly earnings and guidance updates remain the most direct catalysts for the stock forecast.
AI Daily Buy/Sell Signals use artificial intelligence to continuously monitor thousands of stocks and ETFs, generating Buy, Sell, or Hold signals based on changing market conditions, technical behavior, and AI-driven analysis. The tool helps traders discover opportunities, track existing positions, and identify shifting trends more efficiently than manual screening alone. For investors evaluating names like Lineage, these signals can complement fundamental research with a systematic, data-driven view of short-term momentum. Explore the platform to see how AI-powered signals can support a more disciplined approach to monitoring your watchlist.
Reaching $46 would require Lineage to climb roughly 16% and clear its 52-week high, a substantial move that depends on a genuine turnaround in occupancy, margins, and adjusted FFO. The bull case rests on stabilizing demand, moderating supply, cost discipline, and a high dividend yield, while the bear case emphasizes negative earnings, elevated leverage, and a wide analyst range from $35 to $55. With the overall mean target near $43 and strong disagreement among analysts, the path to $46 is possible but far from assured. Investors should monitor quarterly results, guidance, and analyst revisions before drawing conclusions.
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
A.I.dvisor indicates that over the last year, LINE has been closely correlated with COLD. These tickers have moved in lockstep 73% of the time. This A.I.-generated data suggests there is a high statistical probability that if LINE jumps, then COLD could also see price increases.
| Ticker / NAME | Correlation To LINE | 1D Price Change % | ||
|---|---|---|---|---|
| LINE | 100% | -12.05% | ||
| COLD - LINE | 73% Closely correlated | +0.50% | ||
| CUBE - LINE | 47% Loosely correlated | +0.04% | ||
| EXR - LINE | 45% Loosely correlated | -0.76% | ||
| REXR - LINE | 43% Loosely correlated | -1.94% | ||
| PSA - LINE | 42% Loosely correlated | -0.66% | ||
More | ||||
| Ticker / NAME | Correlation To LINE | 1D Price Change % |
|---|---|---|
| LINE | 100% | -12.05% |
| LINE (2 stocks) | 93% Closely correlated | +0.87% |
| Miscellaneous Manufacturing (15 stocks) | 5% Poorly correlated | +0.38% |
| Producer Manufacturing (346 stocks) | 2% Poorly correlated | +0.99% |